Shao, S. & Hegde, R. S. Membrane protein insertion at the endoplasmic reticulum. Annu. Rev. Cell Dev. Biol. 27, 25–56 (2011).
Article CAS PubMed PubMed Central Google Scholar
Egea, P. F., Stroud, R. M. & Walter, P. Targeting proteins to membranes: structure of the signal recognition particle. Curr. Opin. Struct. Biol. 15, 213–220 (2005).
Article CAS PubMed Google Scholar
Voorhees, R. M. & Hegde, R. S. Toward a structural understanding of co-translational protein translocation. Curr. Opin. Cell Biol. 41, 91–99 (2016).
Article CAS PubMed Google Scholar
Rapoport, T. A., Li, L. & Park, E. Structural and mechanistic insights into protein translocation. Annu. Rev. Cell Dev. Biol. 33, 369–390 (2017).
Article CAS PubMed Google Scholar
Liaci, A. M. et al. Structure of the human signal peptidase complex reveals the determinants for signal peptide cleavage. Mol. Cell. 81, 3934–3948 (2021).
Article CAS PubMed Google Scholar
Blobel, G. & Dobberstein, B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J. Cell Biol. 67, 835–851 (1975).
Article CAS PubMed Google Scholar
Von Heijne, G. Signal sequences: the limits of variation. J. Mol. Biol. 184, 99–105 (1985).
Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 40, 1023–1025 (2022).
Article CAS PubMed PubMed Central Google Scholar
Nielsen, H., Tsirigos, K. D., Brunak, S. & von Heijne, G. A brief history of protein sorting prediction. Protein J. 38, 200–216 (2019).
Article CAS PubMed PubMed Central Google Scholar
Voorhees, R. M. & Hegde, R. S. Structure of the Sec61 channel opened by a signal sequence. Science 351, 88–91 (2016).
Article ADS CAS PubMed PubMed Central Google Scholar
Hegde, R. S. & Kang, S. W. The concept of translocational regulation. J. Cell Biol. 182, 225–232 (2008).
Article CAS PubMed PubMed Central Google Scholar
Besemer, J. et al. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 436, 290–293 (2005).
Article ADS CAS PubMed Google Scholar
Garrison, J. L., Kunkel, E. J., Hegde, R. S. & Taunton, J. A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum. Nature 436, 285–289 (2005).
Article ADS CAS PubMed Google Scholar
Meyer, L. K. et al. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukemia. Br. J. Haematol. 198, 137–141 (2022).
Article CAS PubMed PubMed Central Google Scholar
Rehan, S. et al. Signal peptide mimicry primes Sec61 for client-selective inhibition. Nat. Chem. Biol. 19, 1054–1062 (2023).
Article CAS PubMed PubMed Central Google Scholar
MacKinnon, A. L., Garrison, J. L., Hegde, R. S. & Taunton, J. Photo-leucine incorporation reveals the target of a cyclodepsipeptide inhibitor of cotranslational translocation. J. Am. Chem. Soc. 129, 14560–14561 (2007).
Article CAS PubMed PubMed Central Google Scholar
Maifeld, S. V. et al. Secretory protein profiling reveals TNF-α inactivation by selective and promiscuous sec61 modulators. Chem. Biol. 18, 1082–1088 (2011).
Article CAS PubMed Google Scholar
Mackinnon, A. L. et al. An allosteric Sec61 inhibitor traps nascent transmembrane helices at the lateral gate. eLife 3, e01483 (2014).
Article PubMed PubMed Central Google Scholar
Harant, H. et al. The translocation inhibitor CAM741 interferes with vascular cell adhesion molecule 1 signal peptide insertion at the translocon. J. Biol. Chem. 281, 30492–30502 (2006).
Article CAS PubMed Google Scholar
Harant, H. et al. Inhibition of vascular endothelial growth factor cotranslational translocation by the cyclopeptolide CAM741. Mol. Pharmacol. 71, 1657–1665 (2007).
Article CAS PubMed Google Scholar
Itskanov, S. et al. A common mechanism of Sec61 translocon inhibition by small molecules. Nat. Chem. Biol. 19, 1063–1071 (2023).
Article CAS PubMed Google Scholar
Ruiz-Saenz, A. et al. Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum. Oncogene 34, 5288–5294 (2015).
Article CAS PubMed PubMed Central Google Scholar
Jura, N., Shan, Y., Cao, X., Shaw, D. E. & Kuriyan, J. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proc. Natl Acad. Sci. USA 106, 21608–21613 (2009).
Article ADS CAS PubMed PubMed Central Google Scholar
Baselga, J. & Swain, S. M. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9, 463–475 (2009).
Article CAS PubMed Google Scholar
Soltoff, S. P., Carraway, K. L., Prigent, S. A., Gullick, W. G. & Cantley, L. C. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14, 3550–3558 (1994).
CAS PubMed PubMed Central Google Scholar
Wang, Z. et al. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nat. Commun. 12, 2383 (2021).
Article ADS CAS PubMed PubMed Central Google Scholar
Wilson, T. R., Lee, D. Y., Berry, L., Shames, D. S. & Settleman, J. Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers. Cancer Cell 20, 158–172 (2011).
Article CAS PubMed Google Scholar
Ogbechi, J. et al. Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4. Cell Death Dis. 9, 397 (2018).
Article PubMed PubMed Central Google Scholar
Domenger, A. et al. The Sec61 translocon is a therapeutic vulnerability in multiple myeloma. EMBO Mol. Med. 14, e14740 (2022).
Article CAS PubMed PubMed Central Google Scholar
Drilon, A. et al. Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers. Cancer Discov. 8, 686–695 (2018).
Article CAS PubMed PubMed Central Google Scholar
Gan, H. K. et al. A phase I, first-in-human study of GSK2849330, an anti-HER3 monoclonal antibody, in HER3-expressing solid tumors. Oncologist 26, e1844–e1853 (2021).
Article CAS PubMed PubMed Central Google Scholar
Devaraneni, P. K. et al. Stepwise insertion and inversion of a type II signal anchor sequence in the ribosome-Sec61 translocon complex. Cell 146, 134–147 (2011).
Article CAS PubMed PubMed Central Google Scholar
Vermeire, K. et al. Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation. PLoS Biol. 12, e1002011 (2014).
Article PubMed PubMed Central Google Scholar
Chitwood, P. J., Juszkiewicz, S., Guna, A., Shao, S. & Hegde, R. S. EMC is required to initiate accurate membrane protein topogenesis. Cell 175, 1507–1519 (2018).
Article CAS PubMed PubMed Central Google Scholar
Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5, 1–20 (2016).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10 (2011).
留言 (0)